Aadi bioscience to report second quarter 2024 results and corporate update

Company to host conference call and webcast on august 7, 2024 los angeles , july 31, 2024 /prnewswire/ -- aadi bioscience, inc. (nasdaq: aadi), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers with alterations in the mtor pathway, today announced that it will host a conference call and live webcast on wednesday, august 7, 2024, at 8:30 am edt (5:30 am pdt) to report second quarter 2024 financial results and provide recent corporate updates. conference call information participants may access a live webcast of the call on the "investors & news" page of the aadi bioscience website at aadibio.com.
AADI Ratings Summary
AADI Quant Ranking